HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions.
about
HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@en
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@nl
type
label
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@en
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@nl
prefLabel
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@en
HLA-B*1502 haplotype screening ...... aneous adverse drug reactions.
@nl
P2860
P356
P1476
HLA-B*1502 haplotype screening ...... taneous adverse drug reactions
@en
P2093
Ian McCrossin
P2860
P304
P356
10.1111/AJD.12754
P577
2017-12-11T00:00:00Z